These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9350245)

  • 21. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].
    Kameoka H; Katayose K; Kumakawa K; Shiraiwa Y; Uchida H; Takahashi Y; Yazaki J; Yamaguchi O
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):57-63. PubMed ID: 15675583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
    Pai HH; Eldridge B; Bishop D; Alexander A; Lesperance M; Blood P; Lim J; Ludgate C
    Can J Urol; 2009 Apr; 16(2):4541-52. PubMed ID: 19364426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
    Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
    J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.
    Berruti A; Fara E; Tucci M; Tarabuzzi R; Mosca A; Terrone C; Gorzegno G; Fasolis G; Tampellini M; Porpiglia F; De Stefanis M; Fontana D; Bertetto O; Dogliotti L;
    Urol Oncol; 2005; 23(1):1-7. PubMed ID: 15885575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
    Kelly WK; Halabi S; Elfiky A; Ou SS; Bogart J; Zelefsky M; Small E;
    Cancer; 2008 Dec; 113(11):3137-45. PubMed ID: 18989865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Greco FA; Morrissey LH; Raefsky EL; Steis RG; Butts JA; Hainsworth JD;
    Cancer; 2003 Nov; 98(10):2192-8. PubMed ID: 14601089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advanced gastric cancer curatively resected following combined neoadjuvant chemotherapy--report of a case].
    Koike N; Ohwada S; Ogawa T; Kawashima K; Takeyoshi I; Sato Y; Kamiyama H; Morishita Y
    Gan To Kagaku Ryoho; 1998 May; 25(6):919-23. PubMed ID: 9617332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
    Zincke H; Lau W; Bergstralh E; Blute ML
    J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot trial of adjuvant paclitaxel plus estramustine in resected high-risk prostate cancer.
    Cetnar JP; Malkowicz SB; Palmer SC; Wein AJ; Vaughn DJ
    Urology; 2008 May; 71(5):942-6. PubMed ID: 18279928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate.
    Seay TM; Blute MC; Zincke H
    Urology; 1997 Dec; 50(6):833-7. PubMed ID: 9426709
    [No Abstract]   [Full Text] [Related]  

  • 33. Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy.
    Moreau JP; Delavault P; Blumberg J
    Clin Ther; 2006 Oct; 28(10):1485-508. PubMed ID: 17157109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological significance of neoadjuvant hormonal therapy prior to radical prostatectomy: whole section analysis].
    Uemura H; Cho M; Hirao Y; Konishi N
    Hinyokika Kiyo; 2002 Nov; 48(11):719-23. PubMed ID: 12512148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP chemotherapy].
    Shioiri T; Inoue S; Kusano T; Umekita N; Kitamura M; Warabi M; Kawahara Y
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1327-30. PubMed ID: 16184934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration.
    Oefelein MG
    J Urol; 1998 Nov; 160(5):1685-8. PubMed ID: 9783932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A survey of radical surgery without neoadjuvant therapy for patients with stage B and C prostatic carcinoma].
    Matsuzaki J; Kanda F; Watanabe T; Ouchi H; Tsuchiya F; Fukuda M; Satomi Y
    Hinyokika Kiyo; 2001 Jan; 47(1):5-10. PubMed ID: 11235223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prostatic cancer with cystic formation: a case report].
    Kubo M; Taguchi K; Fujisue H; Ihara H; Ikoma F
    Hinyokika Kiyo; 1998 Dec; 44(12):883-6. PubMed ID: 10028435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin-releasing hormone agonist failure in a man with prostate cancer.
    Smith MR; McGovern FJ
    J Urol; 2001 Jul; 166(1):211. PubMed ID: 11435862
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study on etoposide therapy of relapsing prostatic cancer patients].
    Moriyama M; Murai T; Kondoh I
    Hinyokika Kiyo; 1990 Jul; 36(7):777-81. PubMed ID: 2239575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.